kidney disease
Renalytix Q2 Revenues More Than Doubles, Firm Announces $30M Financing Round
The firm is registered as a vendor to enable KidneyIntelX testing services for acute and chronic kidney disease at 16 Veterans Health Administration (VHA) health centers.
The study looked at Black patients with the APOL1 genotype, a signifier of increased risk of kidney failure.
BTIG Initiates Coverage of Kidney Disease Diagnostics Firm Renalytix With Buy Rating
Renalytix has developed a blood-based KidneyIntelX test that provides a patient risk score to predict progressive kidney function decline or failure.
Becton Dickinson, Siemens Healthineers, Abbott Laboratories, Others Nab FDA Clearances in November
BioMérieux obtained FDA clearance for a multiplex RT-PCR assay that detects SARS-CoV-2 RNA in nasopharyngeal swabs from symptomatic individuals.
Renalytix Posts $1.5M in Revenues for Fiscal 2021
The maker of IVD tests for kidney disease also reported a net loss of $35.4 million, or $.49 per share, for the 12 months ended June 30.
Apr 14, 2021
Calciscon Raises $2.7M in Series A Round
Mar 19, 2021
Mar 17, 2021
Mar 16, 2021
NephroSant Raises $16M in Series A Funding Round
Mar 2, 2021
RenalytixAI Reports Q2 2021 Revenues of $400K
Aug 24, 2020